Related Experiment Video
Updated: Jan 11, 2026

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System
Published on: June 11, 2020
Agonizing GABABR suppresses GLP-1RA's chronotropic effect and reduces post-myocardial infarction arrhythmogenesis
Run Qi1,2,3, Zhang Jingjing4,5,6, Gu Hongchang1,2
1Department of Cardiology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Insights
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) impact heart rhythm via cardiac-autonomous mechanisms involving the GABAB receptor. GABABR activation counteracts GLP-1RA tachycardia but enhances anti-arrhythmic effects post-myocardial infarction.
Area of Science:
- Cardiology
- Neuropharmacology
- Molecular Biology
Background:
- Glucagon-like peptide-1 receptor agonists (GLP-1RAs) show cardiovascular benefits independent of glucose control.
- The precise mechanisms by which GLP-1RAs influence cardiac rhythm remain incompletely understood and are a subject of ongoing research.
- Investigating novel pathways is crucial for understanding GLP-1RA cardiovascular effects.
Purpose of the Study:
- To elucidate the role of the GABAB receptor (GABABR) in mediating the chronotropic and anti-arrhythmic effects of GLP-1RAs.
- To determine if GLP-1RA actions on heart rhythm are cardiac-autonomous or dependent on sympathetic input.
- To explore the interaction between GABABR and GLP-1R signaling in the context of myocardial infarction (MI).
Main Methods:
- Utilized a murine myocardial infarction model induced by left anterior descending artery ligation.
- Generated cardiomyocyte-specific Gabbr1-knockout mice using adeno-associated virus serotype 9 (AAV9) delivery.
- Assessed cardiac function and electrophysiology using Western blotting, immunofluorescence, in vivo electrophysiology, and patch-clamp recordings.
- Investigated sympathetic influence via 6-hydroxydopamine (6-OHDA) treatment and sympathectomy.
Main Results:
- GLP-1RA administration increased heart rate through a cardiac-autonomous pathway, independent of sympathetic nervous system activity.
- GABABR activation attenuated GLP-1RA-induced tachycardia, while its deficiency exacerbated it.
- GABABR agonism conferred enhanced resistance to ventricular arrhythmias following myocardial infarction in a GLP-1RA-dependent manner.
- Patch-clamp studies indicated that semaglutide could suppress GABABR-induced repolarization in a dose-dependent manner.
Conclusions:
- GABAB receptor activation counterbalances the chronotropic effects of GLP-1RAs.
- GABABR activation synergistically enhances the anti-arrhythmic efficacy of GLP-1RAs in the post-myocardial infarction setting.
- A novel interaction between GABABR and GLP-1R signaling pathways significantly impacts cardiac electrophysiology.
Background:
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been reported to improve cardiovascular outcomes, potentially through glucose metabolism-independent mechanisms. However, their mechanism of heart rhythm remains controversial.
Methods:
We investigated the role of the GABAB receptor (GABABR) in mediating GLP-1RA's chronotropic and anti-arrhythmic effects in a murine myocardial infarction (MI) model. MI was induced by left anterior descending artery ligation. Cardiomyocyte-specific Gabbr1-knockout (Gabbr1 cKO) mice were generated via AAV9-cTnT-Cre delivery to Gabbr1 f/f mice. Cardiac sympathetic denervation was achieved by 6-hydroxydopamine (6-OHDA) treatment and sympathectomy. Mechanistic insights were obtained through Western blotting, immunofluorescence, in vivo electrophysiology, and patch-clamp recordings.
Results:
GLP-1RA increased the heart rate independent of the sympathetic input, suggesting a cardiac-autonomous mechanism. GABABR activation attenuated GLP-1RA-induced tachycardia, whereas Gabrb1 deficiency exacerbated it. GABABR agonism enhanced resistance to ventricular arrhythmias post-MI in a GLP-1RA-dependent manner. Patch-clamp analysis revealed that GABABR-induced repolarization can be suppressed by semaglutide in a dose-dependent manner, indicating the possible mechanism.
Conclusion:
GABABR activation counteracts GLP-1RA's chronotropic effects while synergistically enhancing anti-arrhythmic efficacy post-MI, highlighting a novel GABABR/GLP-1R interaction in cardiac electrophysiology.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
Related Concept Videos
G-Protein Gated Ion Channels
Sensory...
GPCRs Regulate Adenylyl Cylase Activity
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Ligand-Gated Ion Channel Receptor: Gating Mechanism
GPCR Desensitization